Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
05/2012
05/30/2012EP2231652B1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
05/30/2012EP1993584B1 Inhibitors of CXCR4 activity for use in the treatment of ocular disorders
05/30/2012EP1575516B1 Chimeric and humanized antibodies to alpha5 beta1 integrin that modulate angiogenesis
05/30/2012EP1438302B1 New sulfonamide derivatives as d3-receptor ligands
05/30/2012CN1642558B Uses of sapogenins and their derivatives
05/30/2012CN102482315A 肝x受体激动剂 Liver x receptor agonist
05/30/2012CN102482256A N-取代的环状氨基衍生物 N- substituted cyclic amino derivative
05/30/2012CN102481301A 含有拉坦前列素的水性滴眼剂以及抑制拉坦前列素对树脂的吸附的方法 The method of water containing latanoprost latanoprost eye drops and inhibit the absorption of resin
05/30/2012CN102481277A 紫外线损伤减轻口服组合物 UV damage mitigation oral composition
05/30/2012CN102481268A 眼科用组合物和白浊、沉淀的抑制方法 Ophthalmic compositions, and white turbidity, precipitation inhibiting
05/30/2012CN102481011A 含有黄斑色素的叶黄素组合物及其制备方法 Lutein-containing composition and preparation methods of macular pigment
05/30/2012CN102477381A 一种聪耳保健酒 One kind Conger health wine
05/30/2012CN102477065A 一种制备布地奈德的新16,17-缩酮中间体 A method of preparing a new 16,17 budesonide ketal intermediates
05/30/2012CN102477064A 一种制备环索奈德的新的16,17缩酮中间体 A ciclesonide new intermediates for the preparation of 16, 17-ketal
05/30/2012CN102477058A 一种制备布地奈德的新的16,17-二羟基中间体 A process for producing budesonide new 16,17-dihydroxy intermediate
05/30/2012CN102475860A 白塞氏愈溃片 Behcet's Ulcer sheet
05/30/2012CN102475833A 青光眼防治口服液 Glaucoma Prevention Oral
05/30/2012CN102475774A 消炎止痛外敷药膏 Topical anti-inflammatory analgesic creams
05/30/2012CN102475725A 降糖明目丸 Hypoglycemic eyesight pill
05/30/2012CN102475724A 视网膜保护片 Retinal protective sheet
05/30/2012CN102475720A 一种治疗中耳炎的药物 A method of treating otitis media, drug
05/30/2012CN102475696A 一种水溶性叶黄素及其制备工艺 A water-soluble lutein and its preparation process
05/30/2012CN102100802B Chinese medicinal composition for relieving visual fatigue and preparation method thereof
05/30/2012CN102100665B Eye drops containing vitamin E derivatives and preparation method thereof
05/30/2012CN102036675B Use of black soybean for treating ophthalmic diseases
05/30/2012CN101978975B Haematococcus extract preparation, and preparation method and use thereof
05/30/2012CN101961350B Preparation method of fishy smell-removed pearl powder
05/30/2012CN101940419B Novel health-care pillow
05/30/2012CN101822677B Eye drops for cataracts
05/30/2012CN101455825B Erchen decoction preparation method
05/30/2012CN101455628B Preparation method of gel composition for eyes
05/30/2012CN101402675B Target restraint alpha Nu beta3 positive cell proliferation cyclic peptides
05/30/2012CN101278937B Clear eye lotion containing latanoprost as effective ingredient
05/30/2012CN101185710B Powder agent medicine for treating chronic otitis media suppurative
05/29/2012US8188276 2,4-pyrimidinediamine compounds and their uses
05/29/2012US8188074 Biologically active methylene blue derivatives
05/29/2012US8188052 Method for the treatment and prevention of ocular disorders
05/29/2012CA2687927C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
05/29/2012CA2686525C An antihistamine antiallergic agent and a method of deriving it
05/29/2012CA2558944C Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application
05/29/2012CA2555624C Thioamide compounds or salts thereof and cytokine production inhibitors containing the same
05/29/2012CA2496127C Piperidinyl compounds that selectively bind integrins
05/29/2012CA2481036C (3z)-(3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
05/29/2012CA2389429C Compositions and methods for counteracting effects of reactive oxygen species and free radicals
05/24/2012WO2012067941A1 Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
05/24/2012WO2012067427A2 Pharmaceutical composition containing lk8 protein as an active ingredient for preventing or treating diabetic retinopathy or age-related macular degeneration
05/24/2012WO2012067224A1 Therapeutic or prophylactic agent for corneal epithelium disorders and/or conjunctival epithelium disorders
05/24/2012WO2012066994A1 Pharmaceutical formulation having neuroprotective activity
05/24/2012WO2012066171A1 Nanoparticles for the prevention and/or treatment of diseases of the mucus membranes
05/24/2012WO2012016162A3 Compositions, methods and kits for modeling, diagnosing, and treating complement disorders
05/24/2012WO2012015211A3 Opthalmic formulation containing cyclosporine a
05/24/2012US20120129910 Inhibition of Apoptosis-Specific eIF-5A(elF-5A1") with Antisense Oligonucleotides and siRNA as Anti-Inflammatory Therapeutics
05/24/2012US20120129906 Modulators of s1p receptors
05/24/2012US20120129892 Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmethyl)pyridine and their therapeutical uses
05/24/2012US20120129889 Non-competitive NMDA receptor antagonists
05/24/2012US20120129886 Metalloenzyme inhibitor compounds
05/24/2012US20120129879 Compounds and Compositions for Use in Phototherapy and in Treatment of Ocular Neovascular Disease and Cancers
05/24/2012US20120129878 Tablet
05/24/2012US20120129866 Methods for preventing or treating metabolic diseases, inflammatory diseases, autoimmune diseases, allergic diseases, central nervous system diseases, cardiovascular diseases, homeostasis-related diseases or glaucoma
05/24/2012US20120129860 Styrenyl derivative compounds for treating ophthalmic diseases and disorders
05/24/2012US20120129849 Deuterated serine-threonine protein kinase modulators
05/24/2012US20120129847 Compositions and methods for treating ocular edema, neovascularization and related diseases
05/24/2012US20120129830 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof
05/24/2012US20120129829 Novel indole modulators of s1p receptors
05/24/2012US20120129814 Novel phosphonic acids as s1p receptor modulators
05/24/2012US20120129813 Novel compounds as receptor modulators with therapeutic utility
05/24/2012US20120129795 Antiviral compounds
05/24/2012US20120129775 Antiangiogenic small molecules and methods of use
05/24/2012US20120128782 Multicomponent Degradable Cationic Polymers
05/24/2012US20120128763 Lubricant for the ocular surface
05/24/2012US20120128754 Treatment of eye discomfort by topical administration of a cooling agent to the external surface of the eyelid
05/24/2012US20120128707 Streptococcus pneumoniae proteins and nucleic acids
05/24/2012US20120128689 Anti-il-23 immunoglobulins
05/24/2012US20120128679 Human Antibodies to the Glucagon Receptor
05/24/2012US20120128674 C3b antibodies and methods for the prevention and treatment of complement-associated disorders
05/24/2012US20120128657 Synthetic macrocyclic compounds and methods for treating cancer
05/24/2012CA2818612A1 Therapeutic agent formulations for implanted devices
05/24/2012CA2818144A1 Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
05/24/2012CA2817505A1 Pharmaceutical formulation having neuroprotective activity
05/23/2012EP2455467A1 Double-stranded oligonucleotides
05/23/2012EP2455379A1 Crystals of pyrroloquinolinequinone sodium salts
05/23/2012EP2455368A1 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzene- sulfonate, crystals of same, polymorphs thereof, and processes for production thereof
05/23/2012EP2455096A1 Oxidized protein hydrolase activity enhancer
05/23/2012EP2455091A1 Angiogenesis-regulating composition and angiogenesis regulation method
05/23/2012EP2455085A2 Use of at least one compound of the family of the avermectins or of the family of the milbemycins in the treatment of ophthalmic pathologies
05/23/2012EP2454253A1 Aminopyridine derivatives for treating tumors and inflammatory diseases
05/23/2012EP2453748A1 Treatment method
05/23/2012CN102471336A 吡咯并喹啉醌的钠盐结晶 Pyrrolo-quinoline quinone and the crystalline sodium salt of
05/23/2012CN102471333A 新型噻吩甲酰胺衍生物及其药物用途 Novel thiophene carboxamide derivatives and pharmaceutical use
05/23/2012CN102471317A 用于治疗肿瘤和炎性疾病的氨基吡啶衍生物 For the treatment of cancer and inflammatory diseases aminopyridine derivative
05/23/2012CN102471276A 新型四氢异喹啉化合物 Novel tetrahydroisoquinoline compounds
05/23/2012CN102471273A 2-[[[2-[(羟基乙酰基)氨基]-4-吡啶基]甲基]硫代]-n-[4-(三氟甲氧基)苯基]-3-吡啶甲酰胺苯磺酸盐、其晶体、其多晶型物以及用于制备其的方法 2 - [[[2 - [(hydroxy acetyl) amino] -4-pyridyl] methyl] thio] -n- [4- (trifluoromethoxy) phenyl] -3-pyridinecarboxamide benzene sulfonates, crystal, polymorph thereof, and a method for the preparation thereof
05/23/2012CN102470153A 氧化蛋白水解酶活性增强剂 Oxidation proteolytic activity enhancer
05/23/2012CN102470146A Angiogenesis-regulating composition and angiogenesis regulation method
05/23/2012CN102470139A Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections
05/23/2012CN102470135A 抑制jak途径的组合物和方法 Compositions and methods of inhibiting pathways jak
05/23/2012CN102470120A 用于保护眼球的内部结构抵抗紫外线或用于用跨上皮交联技术治疗圆锥角膜的眼用溶液 Internal structure used to protect the eye or for resistance to UV cross-linking technology with transepithelial ophthalmic solution treatment of keratoconus
05/23/2012CN102470115A 硅酮水凝胶隐形眼镜用眼科组合物 A silicone hydrogel contact lens with an ophthalmic composition
05/23/2012CN102465082A 一种降压保健酒 An antihypertensive health wine
05/23/2012CN102465080A 一种保健酒（明目安神）及制备方法 A health wine (eyes and nerves) and preparation method
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 531